Dr. Melissa Chee is an Associate Professor of Neuroscience at Carleton University, Ottawa, Canada. She earned her PhD in Neuroscience from the University of Alberta, Edmonton, Canada, and following her doctoral studies, she pursued postdoctoral research at Beth Israel Deaconess Medical Center, a teaching hospital at Harvard Medical School, Boston,...

Prof. Maria José Diógenes is PharmD, Master in Neurosciences and PhD in Biomedical Sciences, Basic Neurosciences. In 2018 she obtained the Aggregation in Medicine, Pharmacology, Faculty of Medicine, University of Lisbon (FMUL). Prof. Maria José Diógenes is Associate Professor of Pharmacology and General Therapeutics at FMUL, certified pharmacologist by EPHAR...

Dr. Martijn Kerkhofs is a post-doctoral fellow at University Claude Bernard Lyon 1. He earned a Master's degree in Drug Development at KU Leuven (Belgium) in 2016 and went on to obtain a Ph.D. in Biomedical Sciences at the Faculty of Medicine at the same university in 2020. For his...

Academic researcher (> 20 years of experience) with a demonstrated track record of collaboration with pharmaceutical industry. Skilled in Medicinal and Computational Chemistry, Neuropharmacology and Drug Discovery, especially for GPCRs targets. Published over 120 articles in peer-reviewed journals and co-inventor on 8 patents. Originator and co-founder of the Drug Discovery...

Marco Peviani is Associate Professor of Pharmacology at the University of Pavia, Italy. He received his PhD in 2010 from the Open University (UK) and Mario Negri Institute (Italy), studying preclinical models of Amyotrophic Lateral Sclerosis (ALS). As a post-doc at the University of Pavia, he validated Sigma-1 receptor as...

Dr. Manuel Valero is the Group Leader at the Hospital del Mar Medical Research Institute (IMIM) in Barcelona (Spain). He did his postdoc (2018-2022) in the laboratory of György Buzsáki at the NYU Neuroscience Institute in New York, US. Funded by the EMBO and HFSP, Dr. Valero developed novel high-resolution...